Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Bone. 2012 Oct 16;54(2):222–229. doi: 10.1016/j.bone.2012.10.008

Fig. 6.

Fig. 6

Percentage change in serum FGF23 and PTH levels in patients treated with sevelamer hydrochloride (□) or calcium acetate (■) over a 6-wk period.